Peru Air Travel Reopens
The South American country of the Republic of Peru has resumed most transportation options, including airport operations. Other improved conditions such as the resumption of most business operations and a gradual re-opening of borders have been reported within Peru.
Peru began its COVID-19 pandemic economic reactivation plan on October 1, 2020, which included the resumption of a limited number of international flights.
However, prospective travelers to Peru should check the State Department’s travel advisory website for country-specific travel information before deciding to do so, as country-specific regulations may change at any time.
The US Department of State recently issued a Level 3 Travel Advisory for Peru on November 23, 2020, states ‘The U.S. government has limited ability to provide emergency services to U.S. citizens as U.S. government personnel are restricted from traveling within 20 kilometers of the border with Colombia in the Loreto region, except on the Amazon River itself, without permission.’
‘This includes travel on the Putumayo River, which forms most of the Peru-Colombia border.’
As of November 24, 2020, there are no specific limitations on U.S citizens, Lawful Permanent Residents entering the United States from Peru.
This is good news for the 400,000 average annual visitors to Peru.
And when leaving Peru, travelers are not required to have proof of a negative COVID-19 test but must have no COVID-19 symptoms. Face masks AND face shields must be worn at the airport and for the flight duration.
Additionally, the US Centers for Disease Control and Prevention (CDC) issued a level 4 Travel Health Notice for Peru due to the COVID-19 pandemic on November 21, 2020.
Peruvian authorities are reminding everyone that November 1, 2020, was the start of dengue fever season in high prevalence areas. This means those living in Loreto, Ica, Ucayali, San Martín, Junín, and Madre de Dios should take precautions against mosquitoes, including using sprays and mosquito nets.
Peru has already experienced unusually high dengue infections this year since normal prevention measures such as fumigation were not carried out due to Covid-19 restrictions.
Dengue viruses are spread to people through the bite of an infected Aedes species mosquito.
Dengue is common in more than 100 countries around the world. About 3 billion people live in areas with a risk of dengue. Dengue is often a leading cause of illness in areas with risk, says the CDC.
There is one dengue vaccine authorized by the CDC and various countries around the world, with several dengue vaccine candidates in clinical studies.
The first dengue vaccine, known as Dengvaxia, is a recombinant yellow fever-17D–dengue virus, live, attenuated, tetravalent dengue vaccine, produced by Sanofi Pasteur. Dengvaxia was initially licensed for use in individuals aged from 9 to 45 years during 2016.
For additional dengue vaccine information, please visit this webpage.
Vax-Before-Travel publishes research-based travel vaccination news.